CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

Abstract

In this case series, CD19 CAR T-cell transfer appeared to be feasible, safe, and efficacious in three different autoimmune diseases, providing rationale for further controlled clinical trials. (Funded by Deutsche Forschungsgemeinschaft and others.).